These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 24940066)
21. [Effect of early initiation of continuous renal replacement therapy based on the KDIGO classification on the prognosis of critically ill patients with acute kidney injury]. Chen M; Hu B; Li Q; Liu J Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):246-51. PubMed ID: 29917340 [TBL] [Abstract][Full Text] [Related]
25. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study. Muñoz-Pichuante D; Villa-Zapata L J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354 [TBL] [Abstract][Full Text] [Related]
26. Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy. Ulldemolins M; Vaquer S; Llauradó-Serra M; Pontes C; Calvo G; Soy D; Martín-Loeches I Crit Care; 2014 Jun; 18(3):227. PubMed ID: 25042938 [TBL] [Abstract][Full Text] [Related]
27. A Clinician's Guide to Dosing Analgesics, Anticonvulsants, and Psychotropic Medications in Continuous Renal Replacement Therapy. Bouajram RH; Awdishu L Kidney Int Rep; 2021 Aug; 6(8):2033-2048. PubMed ID: 34386653 [TBL] [Abstract][Full Text] [Related]
28. Association of Thrombocytopenia and Mortality in Critically Ill Patients on Continuous Renal Replacement Therapy. Guru PK; Singh TD; Akhoundi A; Kashani KB Nephron; 2016; 133(3):175-82. PubMed ID: 27380175 [TBL] [Abstract][Full Text] [Related]
29. The incidence of thrombocytopenia associated with continuous renal replacement therapy in critically ill patients. Ferreira JA; Johnson DW Ren Fail; 2015 Aug; 37(7):1232-6. PubMed ID: 26108135 [TBL] [Abstract][Full Text] [Related]
30. Clinical and economic impact of clinical pharmacist interventions regarding antimicrobials on critically ill patients. Leache L; Aquerreta I; Aldaz A; Monedero P; Idoate A; Ortega A Res Social Adm Pharm; 2020 Sep; 16(9):1285-1289. PubMed ID: 31327737 [TBL] [Abstract][Full Text] [Related]
31. Development of a continuous renal replacement program in critically ill patients. Gilbert RW; Caruso DM; Foster KN; Canulla MV; Nelson ML; Gilbert EA Am J Surg; 2002 Dec; 184(6):526-32; discussion 532-3. PubMed ID: 12488156 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label Study. Philpott CD; Droege CA; Droege ME; Healy DP; Courter JD; Ernst NE; Harger NJ; Foertsch MJ; Winter JB; Carter KE; Van Fleet SL; Athota K; Mueller EW Pharmacotherapy; 2019 Nov; 39(11):1066-1076. PubMed ID: 31549737 [TBL] [Abstract][Full Text] [Related]
33. Prognostic Impact of Early Versus Late Initiation of Renal Replacement Therapy Based on Early Warning Algorithm in Critical Care Patients With Acute Kidney Injury. Tekdöş Şeker Y; Çukurova Z; Özel Bilgi D; Hergünsel O Ther Apher Dial; 2020 Aug; 24(4):445-452. PubMed ID: 31661596 [TBL] [Abstract][Full Text] [Related]
34. The role of the specialized team in the operation of continuous renal replacement therapy: a single-center experience. Rhee H; Jang GS; Han M; Park IS; Kim IY; Song SH; Seong EY; Lee DW; Lee SB; Kwak IS BMC Nephrol; 2017 Nov; 18(1):332. PubMed ID: 29132321 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of pharmaceutical care in a diabetes ward from China: a pre-and post-intervention study. Xin C; Ge X; Zheng L; Huang P Int J Clin Pharm; 2016 Feb; 38(1):34-40. PubMed ID: 24132736 [TBL] [Abstract][Full Text] [Related]
36. Predictors of 15-Day Survival for the Intensive Care Unit Patient on Continuous Renal Replacement Therapy: A Retrospective Analysis. Siddiqui AH; Valecha G; Modi J; Saqib A; Weerasinghe C; Siddiqui F; El Sayegh S Cureus; 2020 May; 12(5):e8175. PubMed ID: 32440385 [TBL] [Abstract][Full Text] [Related]
37. Accelerated Venovenous Hemofiltration as a Transitional Renal Replacement Therapy in the Intensive Care Unit. Allegretti AS; Endres P; Parris T; Zhao S; May M; Sylvia-Reardon M; Bezreh N; Culbert-Costley R; Ananian L; Roberts RJ; Lopez N; Charytan DM; Tolkoff-Rubin N Am J Nephrol; 2020; 51(4):318-326. PubMed ID: 32097936 [TBL] [Abstract][Full Text] [Related]
38. Antimicrobial Dosing Recommendations in Pediatric Continuous Renal Replacement Therapy: A Critical Appraisal of Current Evidence. Stitt G; Dubinsky S; Edginton A; Huang YV; Zuppa AF; Watt K; Downes K Front Pediatr; 2022; 10():889958. PubMed ID: 35633961 [TBL] [Abstract][Full Text] [Related]
39. Continuous renal replacement therapy in patients with HIV/AIDS. Guo H; Liu J; Pu L; Hao J; Yin N; Liu Y; Xiong H; Li A BMC Nephrol; 2020 Mar; 21(1):95. PubMed ID: 32160882 [TBL] [Abstract][Full Text] [Related]
40. Impact of pharmacists' interventions on physicians' decision of a knowledge-based renal dosage adjustment system. Choi KS; Lee E; Rhie SJ Int J Clin Pharm; 2019 Apr; 41(2):424-433. PubMed ID: 30864079 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]